• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Health Catalyst Inc

    4/30/25 11:10:53 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 7)


    Health Catalyst Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    42225T107

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    42225T107


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    28,612.00
    7Sole Dispositive Power

    4,082,252.00
    8Shared Dispositive Power

    49,401.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    4,131,653.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.88 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Health Catalyst Inc
    (b)Address of issuer's principal executive offices:

    10897 S River Front Pkwy, Suite 3000, South Jordan, UT, 84095
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd., Malvern, PA 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    42225T107
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    4131653
    (b)Percent of class:

    5.88  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    28612

     (iii) Sole power to dispose or to direct the disposition of:

    4082252

     (iv) Shared power to dispose or to direct the disposition of:

    49401

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:04/30/2025
    Get the next $HCAT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    1/3/2024$14.00Overweight
    Barclays
    1/3/2024$11.00In-line → Outperform
    Evercore ISI
    12/13/2023$14.00 → $11.00Neutral → Overweight
    JP Morgan
    11/13/2023$12.00 → $11.00Neutral → Overweight
    Piper Sandler
    8/1/2023$16.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

      SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

      11/14/24 7:51:57 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • SEC Form SC 13G filed by Health Catalyst Inc

      SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

      11/14/24 4:44:34 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

      SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

      11/12/24 3:55:05 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Health Catalyst Reports First Quarter 2025 Results

      SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

      5/7/25 4:03:00 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations

      Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY, April 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a strategic partnership with Microsoft to help healthcare organizations accelerate operational, clinical, and financial performance through AI-driven innovation. The collaboration further builds on Health Catal

      4/29/25 8:30:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025

      SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ125." A live audio webcast will be available online at https://ir.healthcatalyst.com/. A

      4/17/25 8:00:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Lesueur Daniel sold $21,331 worth of shares (5,209 units at $4.10), decreasing direct ownership by 2% to 205,832 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      5/7/25 6:15:45 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Chief Operating Officer Lesueur Daniel sold $21,604 worth of shares (5,209 units at $4.15), decreasing direct ownership by 2% to 211,041 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      4/7/25 7:02:12 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • General Counsel Landry Benjamin sold $62,860 worth of shares (13,827 units at $4.55), decreasing direct ownership by 8% to 160,437 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      3/10/25 4:16:01 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    See more
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care
    • Modern Health Welcomes Adam Brown as Chief Financial Officer

      Strengthens Executive Team with Seasoned Healthcare Finance Leader Modern Health, a leading global workplace mental health platform, today announces the appointment of Adam Brown as Chief Financial Officer. With an extensive background in healthcare finance and operations, including significant experience scaling high-growth healthcare technology companies, Brown brings deep industry expertise to the company. "Adam is a valued addition to Modern Health's leadership team, and we are thrilled to welcome him on board. His impressive track record and deep understanding of both public and private markets strengthens our executive bench as we continue to execute our vision," said Gyre Renwick

      1/15/25 10:16:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

      SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solu

      1/13/25 8:00:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Health Catalyst downgraded by Evercore ISI

      Evercore ISI downgraded Health Catalyst from Outperform to In-line

      4/9/25 8:35:36 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Health Catalyst from Sector Weight to Overweight and set a new price target of $9.00

      1/8/25 7:52:29 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Health Catalyst from Overweight to Sector Weight

      4/10/24 7:47:26 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      2/27/24 4:01:39 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Financials

    Live finance-specific insights

    See more
    • Health Catalyst Reports First Quarter 2025 Results

      SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

      5/7/25 4:03:00 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025

      SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ125." A live audio webcast will be available online at https://ir.healthcatalyst.com/. A

      4/17/25 8:00:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Reports Fourth Quarter and Year End 2024 Results

      SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. "For the full year 2024, I am pleased to share that we achieved strong performance across our business, including total revenue of $307 million and Adjusted EBITDA of $26 million. Additionally, I am encouraged with our Technology segment, which had revenue of $195 million for full-year 2024 and $52 million for the fourth quarter of 2024, which represents 10% growth year-over-year. I am pleased with this pr

      2/26/25 4:03:00 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Health Catalyst Inc

      10-Q - Health Catalyst, Inc. (0001636422) (Filer)

      5/9/25 4:45:02 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Health Catalyst, Inc. (0001636422) (Filer)

      5/7/25 4:08:03 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Amendment: SEC Form 10-K/A filed by Health Catalyst Inc

      10-K/A - Health Catalyst, Inc. (0001636422) (Filer)

      4/30/25 4:32:35 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology